Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Roadmap to operationalize Pharma Initiative into start-up Phase of the African Pooled Procurement Mechanism adopted
- Djibouti Forum wraps up with promising agreements, optimism about economic prospects
- Gabon: GOC and Premier Invest Sign Financing Agreement on Assala Oil Deal
- African Climate Negotiators mull global carbon market opportunities
- Ecowas Bank for Investment and Development to inject usd 200 million into the ghanaian economy
- Djibouti opens its doors to international investors at the inaugural Djibouti Forum
- Senegal – Rwanda: Meeting between two indigenous models
- Sanlam – Allianz: Delphine Traoré and Robert Dommisse are placing their personnel